Skip to content
Search

Latest Stories

GP appointments hit record high despite workforce crisis

October data shows that general practice in England delivered 41.3 million appointments

The number of fully-qualified GPs is steadily increasing, but it’s still fewer than five years ago   

General practice has delivered a record number of appointments despite the workforce crisis, but health leaders warn it is “not sustainable.”

NHS England's latest workforce and appointment data shows that general practice delivered 41.3 million appointments, marking an increase of 3 million compared to last year's record and a significant rise of 10 million from five years ago.


The number of fully-qualified, full-time equivalent (FTE) GPs rose to 28,031 in October, reflecting a 2.4 per cent (663) increase compared to October 2023.

However, Professor Kamila Hawthorne, chair of the Royal College of GPs (RCGP), pointed out that the workforce still has “nearly 100 fewer fully qualified, full-time equivalent GPs” than in 2019.

“Whilst this shows the dedication of GPs and our teams to ensure patients receive the care they need, it is not sustainable,” she said, expressing concern that the mounting workload is leading many GPs to experience burnout.

A recent RCGP survey revealed that over 40 per cent of GPs are unlikely to remain in general practice in five years, with more than half saying they find the job ‘too stressful.’

Professor Hawthorne also referenced the Lord Darzi review, which acknowledged that primary care consistently delivers more care, with a shrinking proportion of the NHS budget.

She warned that rising pressures on general practice are affecting patient access to care.

“We’ve heard some encouraging proposals from the new government to move more resource into primary care, but the pressures remain – and worsen – month by month, and it is our most vulnerable patients who are bearing the brunt when they struggle to access our care,” she said.

“With winter fast approaching, our services will only get busier – and uncertainty around how the hike in National Insurance for employers will impact practices is only adding to the pressures general practice is facing.”

“We need action now to alleviate the workforce crisis,” Professor Hawthorne continued, calling for urgent investment in general practice, including schemes to recruit and retain GPs to maintain the high-quality care patients deserve.

Jake Beech, Health Foundation policy fellow, noted that the workforce crisis is contributing to declining patient satisfaction.

“These numbers speak to the huge effort that has gone into meeting the high level of demand for primary care, but need to be seen within the context of declining patient satisfaction and high numbers of GPs struggling to manage overwhelming patient demand,” he said.

NHSE data shows that the number of fully qualified, permanent FTE GPs was 27,519 in October 2024, compared to 28,590 in September 2015.

“Although the expansion of other staff working in general practice – like pharmacists and paramedics – has helped to expand the number of appointments available, these staff cannot replace GPs who are responsible for managing the most complex cases.

“If the government is serious about its ambitions to move care out of hospital and into primary care then it needs to ensure general practice is given the resources it needs to recruit and retain more GPs, especially in the most deprived areas which are particularly under-doctored,” he added.

Beech also called for greater investment in training and staff development, as well as creating the right conditions to retain workers.

More For You

Pharmacist Support calls for birthday donations to meet rising demand for mental health services

More and more pharmacy professionals are reaching out for help, said Danielle Hunt.

Pharmacist Support's birthday appeal: Donate to address growing mental health demand

Pharmacist Support – the independent charity dedicated to the pharmacy profession – is celebrating 184 years of service with the launch of a special birthday donations appeal.

On 15 April, the charity is urging individuals and organisations across the sector to support its campaign to raise vital funds to meet the increasing demand for its mental health and wellbeing services.

Keep ReadingShow less
Prostate cancer: At-home saliva test could save NHS £500 million annually

PRS saliva test can identify prostate cancer that was missed by an MRI scan

Photo credit: gettyimages

Prostate cancer: Spit test better than blood test in spotting men at highest risk

A simple at-home spit test could help detect prostate cancer earlier, saving the NHS around £500 million a year, according to new research published in the New England Journal of Medicine.

Funded by the National Institute for Health and Care Research (NIHR), the study found that the DNA-based saliva test was more accurate than the current prostate-specific antigen (PSA) blood test in identifying men at risk of developing prostate cancer.

Keep ReadingShow less
RPS launches innovative new learning resources for members

With RPS Learn, pharmacists can develop a new skill or improve their understanding of practice or a clinical topic.

Gettyimages

RPS launches new learning resources to boost career development for members

The Royal Pharmaceutical Society (RPS) has launched a new online learning platform designed to support the practice, development and career advancement of its members.

The new platform, called RPS Learn, offers a diverse range of bite-size learning content, available on-demand, catering to all levels — from introductory to advanced and specialist —combining new content with RPS's renowned expertise in education and training to achieve excellence for learners.

Keep ReadingShow less
NICE approves AstraZeneca’s twice-a-day tablet ‘capivasertib’ for advanced breast cancer

HR-positive, HER2-negative advanced breast cancer is currently incurable, and treatment aims to slow progression and prolong life

Gettyimages

NICE approves twice-a-day tablet for advanced breast cancer

Every year, thousands of people with hormone receptor (HR)-positive HER2-negative breast cancer could benefit from a new twice-a-day tablet, now set to be funded immediately through the Cancer Drugs Fund.

The National Institute for Health and Care Excellence (NICE) has approved the use of capivasertib (also known as Truqap), in combination with fulvestrant, as an option for around 1,100 adults with HR-positive HER2-negative breast cancer that has certain genetic mutations and has spread.

Keep ReadingShow less
ABPI and government fast-track VPAG scheme review to address high medicine payment rates

The 2025 VPAG payment rate for newer medicines has been set at 22.9 per cent.

Photo credit: gettyimages

Review of 2024 VPAG scheme to be completed by June

The Association of the British Pharmaceutical Industry (ABPI) and the government have agreed to bring forward a planned review of the 2024 Voluntary Scheme for Branded Medicines Pricing, Access, and Growth (VPAG), originally scheduled for autumn 2025.

The review is expected to be completed in June 2025, aligning with the anticipated release of the government’s 10-year NHS Plan and the Life Sciences Sector Plan as part of the broader industry strategy this summer.

Keep ReadingShow less